Albert M. Maguire

Shares of Spark Therapeutics Inc (NASDAQ: ONCE) opened higher by more than 40 percent on Monday. Spark's product candidate, SPK-RPE65, targets a group of rare blinding conditions known as inherited retinal dystrophies. Spark announced on Monday its SPK-RPE65 met the goals of a late-stage study....